Abstract:Objective To establish a murine model of neutrophilic steroid-refractory asthma for a better exploration of its pathogenesis and treatment.Methods A mouse model of neutrophilic steroid-refractory asthma was established by intratracheal administration of a mixture of house dust mite (HDM) and lipopolysaccharide (LPS).Eighteen female C57BL/6 mice were randomly divided into a control group,an asthma group (HDM + LPS) and a dexamethasone (Dex) group (HDM + LPS + Dex).The airway resistance was measured by pulmonary function test.Airway inflammation,hypersecretion and inflammatory cell recruitment were observed by HE,PAS and Wright's staining,respectively.Inflammatory mediators in lung and bronchoalveolar lavage fluid (BALF) were detected by PCR and ELISA.Th17 cell differentiation in the lung was analyzed by flow cytometry.Results HE staining showed a significantly increased airway inflammation in the asthma group than that in the control group (P＜0.05),and a slightly decreased airway inflammation in the Dex group than that in the asthma group (P＞0.05).Cell counts in BALF showed a sharply elevated recruitment of inflammatory cells in the asthma group (except eosinophils) than that in the control group (total number of inflammatory cells (2797±400)× 106/L vs (105±75)× 106/L,neutrophiis (1151±395)×106/L vs (12±6)×106/L,lymphocytes(897± 135)× 106/L vs (11±5)×106/L,macrophages (215±51)× 106/L vs (34± 16)× 106/L,P＜0.05).Compared with the asthma group,Dex group significantly reduced the recruitment of total number of inflammatory cells and macrophages [total number of inflammatory cells (1140±418) × 106/L vs (2797±400)× 106/L,macrophages (117±31)×106/L vs (215±51)×106/L,all P＜0.05]albeit no significances in lymphocytes and neutrophils [lymphocytes (587±208)× 106/L vs (897± 135)× 1 06/L,neutrophils (294± 134)×106/L vs (1151 ± 395)× 106/L,all P＞0.05].Immunohistochemical staining confirmed that Dex could not effectively alleviate the neutrophilic inflammation in asthmatic mice.Although there was no significant difference in airway hyperreactivity between the asthma group and the Dex group (P＞0.05),both had a higher airway hyperreactivity than that of the control group (P＜0.05).The Dex group exhibited a significantly lower Th2-related inflammatory mediators in the lung than the asthma group(all P＜0.05),together with an increased trend in Th17 cell-related inflammatory mediators and no improvement in Th1-related inflammatory mediators.Flow cytometry showed an obviously increased percentage of Th 17 cells in the Dex group than that in the asthma group [(5.8 ± 1.9)％ vs (2.3 ±0.8)％,P＜0.01].Conluusion A novel murine model mimicking clinical neutrophilic asthma was elegantly established,in which Dex could not attenuate the neutrophilic airway inflammation and hyperreactivity,but rather augmented Th17 cell differentiation,demonstrating the presence of steroid-resistance.

Bcl-2 Antagonist ABT-737 Attenuates Corticosteroid-Insensitive Neutrophilic Airway Inflammation

Induction of Granulocyte Apoptosis by Bcl-2 Inhibitors Reduces Steroid-Insensitive Airway Inflammation

Bcl-2 Inhibitors Reduce Steroid-Insensitive Airway Inflammation.

Altered Frequency of NK Cells and Treg Cells by Astragalus Polysaccharide Combined with Budesonide in Asthma Model Mice

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

Nanoformulated ABT-199 to Effectively Target Bcl-2 at Mitochondrial Membrane Alleviates Airway Inflammation by Inducing Apoptosis

Bruton's tyrosine kinase inhibition suppresses neutrophilic inflammation and restores histone deacetylase 2 expression in myeloid and structural cells in a mixed granulocytic mouse model of asthma

Induction of Neutrophil Apoptosis by a Bcl-2 Inhibitor Reduces Particulate Matter-Induced Lung Inflammation

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Cortistatin protects against inflammatory airway diseases through curbing CCL2 and antagonizing NF-κB signaling pathway

Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats

IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics

Site-specific inhibition of neutrophilic inflammation by low-dose nanotherapy for immunoregulatory treatment of asthma

Celastrol alleviates airway hyperresponsiveness and inflammation in obese asthma through mediation of alveolar macrophage polarization

The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse

Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells

Intracerebroventricular injection of leukotriene B 4 attenuates antigen-induced asthmatic response via BLT1 receptor stimulating HPA-axis in sensitized rats

Short-term Intratracheal Use of PEG-modified IL-2 and Glucocorticoid Persistently Alleviates Asthma in a Mouse Model

Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway

Establishment of a mouse model mimicking neutrophilic steroid-refractory asthma